76 related articles for article (PubMed ID: 11836458)
1. Antibody-induced lysis of isolated rat epididymal adipocytes and complement activation in vivo.
Dickinson K; North TJ; Telford G; Smith SE; Edwards BM; Main SH; Field R; Hatton D; Vaughan TJ; Flint DJ; Jones RB
Obes Res; 2002 Feb; 10(2):122-7. PubMed ID: 11836458
[TBL] [Abstract][Full Text] [Related]
2. Mapping of binding epitopes of a human decay-accelerating factor monoclonal antibody capable of enhancing rituximab-mediated complement-dependent cytotoxicity.
Guo B; Ma ZW; Li H; Xu GL; Zheng P; Zhu B; Wu YZ; Zou Q
Clin Immunol; 2008 Aug; 128(2):155-63. PubMed ID: 18502181
[TBL] [Abstract][Full Text] [Related]
3. Therapy with monoclonal antibodies. An in vivo model for the assessment of therapeutic potential.
Isaacs JD; Clark MR; Greenwood J; Waldmann H
J Immunol; 1992 May; 148(10):3062-71. PubMed ID: 1578132
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the complement-mediated elimination of red blood cells modified with biotin and streptavidin.
Muzykantov VR; Murciano JC; Taylor RP; Atochina EN; Herraez A
Anal Biochem; 1996 Oct; 241(1):109-19. PubMed ID: 8921172
[TBL] [Abstract][Full Text] [Related]
5. Heparin inhibition of antibody-dependent complement-mediated lysis.
Wesolowski J; Ault K; Houghton R; Parkman R
Exp Hematol; 1984 Oct; 12(9):700-5. PubMed ID: 6237929
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of antibody-dependent mechanisms of tumor cell lysis by a targeted activator of complement.
Imai M; Ohta R; Varela JC; Song H; Tomlinson S
Cancer Res; 2007 Oct; 67(19):9535-41. PubMed ID: 17909064
[TBL] [Abstract][Full Text] [Related]
7. Anti-alphaGal-dependent complement-mediated cytotoxicity in metastatic melanoma.
Larkin JM; Norsworthy PJ; A'Hern RP; Eisen TG; Gore ME; Porter CD
Melanoma Res; 2006 Apr; 16(2):157-63. PubMed ID: 16567971
[TBL] [Abstract][Full Text] [Related]
8. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.
Alvarez-Rueda N; Leprieur S; Clémenceau B; Supiot S; Sébille-Rivain V; Faivre-Chauvet A; Davodeau F; Paris F; Barbet J; Aubry J; Birklé S
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5613s-5620s. PubMed ID: 17875797
[TBL] [Abstract][Full Text] [Related]
9. Anti-heat shock protein 90beta antibodies decrease pre-oligodendrocyte population in perinatal and adult cell cultures. Implications for remyelination in multiple sclerosis.
Cid C; Alvarez-Cermeño JC; Salinas M; Alcázar A
J Neurochem; 2005 Oct; 95(2):349-60. PubMed ID: 16135098
[TBL] [Abstract][Full Text] [Related]
10. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
11. Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59.
Ziller F; Macor P; Bulla R; Sblattero D; Marzari R; Tedesco F
Eur J Immunol; 2005 Jul; 35(7):2175-83. PubMed ID: 15971270
[TBL] [Abstract][Full Text] [Related]
12. An anti-adipocyte monoclonal antibody is cytotoxic to porcine preadipocytes in vitro and depresses the development of pig adipose tissue.
De clercq L; Mourot J; Genart C; Davidts V; Boone C; Remacle C
J Anim Sci; 1997 Jul; 75(7):1791-7. PubMed ID: 9222835
[TBL] [Abstract][Full Text] [Related]
13. Pathway-specific complement activity in pigs evaluated with a human functional complement assay.
Salvesen B; Mollnes TE
Mol Immunol; 2009 May; 46(8-9):1620-5. PubMed ID: 19328551
[TBL] [Abstract][Full Text] [Related]
14. The novel chimeric anti-NCAM (neural cell adhesion molecule) antibody ch.MK1 displays antitumor activity in SCID mice but does not activate complement-dependent cytolysis (CDC).
Klehr M; Koehl U; Mühlenhoff M; Tawadros S; Fischer T; Schomäcker K; Heuckmann JM; Bochennek K; Jensen M
J Immunother; 2009 Jun; 32(5):442-51. PubMed ID: 19609236
[TBL] [Abstract][Full Text] [Related]
15. Biological activities on T lymphocytes of a baculovirus-expressed chimeric recombinant IgG1 antibody with specificity for the CDR3-like loop on the D1 domain of the CD4 molecule.
Troadec S; Bès C; Chentouf M; Nguyen B; Briant L; Jacquet C; Chebli K; Pugnière M; Roquet F; Cerutti M; Chardès T
Clin Immunol; 2006 Apr; 119(1):38-50. PubMed ID: 16426893
[TBL] [Abstract][Full Text] [Related]
16. Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinoma.
Macor P; Mezzanzanica D; Cossetti C; Alberti P; Figini M; Canevari S; Tedesco F
Cancer Res; 2006 Apr; 66(7):3876-83. PubMed ID: 16585216
[TBL] [Abstract][Full Text] [Related]
17. Novel IgE peptide-based vaccine prevents the increase of IgE and down-regulates elevated IgE in rodents.
Peng Z; Liu Q; Wang Q; Rector E; Ma Y; Warrington R
Clin Exp Allergy; 2007 Jul; 37(7):1040-8. PubMed ID: 17581197
[TBL] [Abstract][Full Text] [Related]
18. In vitro antitumoral activity of baculovirus-expressed chimeric recombinant anti-CD4 antibody 13B8.2 on T-cell lymphomas.
Troadec S; Chentouf M; Cérutti M; Nguyen B; Olive D; Bès C; Chardès T
J Immunother; 2007; 30(2):190-202. PubMed ID: 17471166
[TBL] [Abstract][Full Text] [Related]
19. High sodium intake enhances insulin-stimulated glucose uptake in rat epididymal adipose tissue.
Fonseca-Alaniz MH; Takada J; Andreotti S; de Campos TB; Campaña AB; Borges-Silva CN; Lima FB
Obesity (Silver Spring); 2008 Jun; 16(6):1186-92. PubMed ID: 18369340
[TBL] [Abstract][Full Text] [Related]
20. [Immunization with targeted fusion anticaries DNA vaccine via intramuscular route:experiment with murine].
Yu F; Fan MW; Xu QA; Jia R; Guo JH; Bian Z; Chen Z; Peng B; Fan B
Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):754-9. PubMed ID: 15200917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
